Apollo Hospitals India launch DNA based diagnostics with Sri Lanka’s Credence Genomics for infectious diseases

The Apollo Hospitals Group, India’s largest integrated healthcare provider announced the launch of a portfolio of cutting edge diagnostics services for infectious diseases.

The new line of tests are being offered in partnership with Credence Genomics, and are based on a specialized DNA diagnostics platform offering faster and more precise diagnosis.

Through this partnership, Credence Genomics’ flagship products – the Rapid Infection Detection (RID), Bactfast and Fungifast will now be readily available to benefit patients and assist the medical fraternity in India by offering fast and precise diagnosis for infectious diseases.

While announcing the launch, Dr. Preetha Reddy, Vice Chairperson, Apollo Hospitals Group, said “It has been our constant endeavor to ensure the most superior technology-based clinical solutions are made available to our patients.

Through the introduction of this service portfolio, patients will benefit immensely through faster and more accurate diagnosis for infectious diseases.

Bacterial and fungal infectious diseases take a great toll on populations of the sub-continent.

The need for effective and timely diagnosis can significantly lower morbidity and mortality associated with this disease cohort.

Through this partnership we are hopeful of offering a meaningful change to the diagnostics landscape in our country.”

The diagnostic products Credence RID, Bactfast and Fungifast are diagnostic tests which can diagnose any infectious disease caused by a bacteria or fungi with over 90% accuracy.

The scope, methodology and accuracy of results are further corroborated by a recent BioMed Central (BMC) Infectious Diseases publication.

These tests, now proven for their speed and accuracy in the reporting of results, have established the trust of the medical community in the domestic market in both public and private sector hospitals.

Dr. Vaz Gnanam, Founding CEO and Director, Credence Genomics further added, “We join hands with the Apollo Group in delivering the highest standards in healthcare in total alignment to their global credibility and brand promise.

We are very excited to explore pioneering endeavors on which both companies could come together, to benefit society beyond the boundaries of countries and territories in the realm of medical science and its progress”.

Credence Genomics is a Sri Lankan establishment pioneering in the development of leading-edge innovations on specialized DNA diagnostics based on the next generation sequencing platform with intensive research infrastructure and capabilities.

As part of the collaborations Credence Genomics will set up a state-of-the-art DNA research/diagnostics facility in Chennai.

The facility will be managed by a team of leading scientists from all across India and will be fully operational by mid-December.

About Apollo Hospitals Enterprise Ltd. (AHEL)

It was in 1983, that Dr. Prathap Reddy made a pioneering endeavour by launching India’s first corporate hospital - Apollo Hospitals in Chennai.

Over the years Apollo Hospitals has established itself as home to the largest cardiac practice in India with over 160,000 cardiac surgeries. Apollo Hospitals is also the world’s largest private cancer care provider and runs the world’s leading solid organ transplant program.

As Asia’s largest and most trusted healthcare group, its presence includes 9,215 beds across 64 Hospitals, 2,500 Pharmacies, over 90 Primary Care and Diagnostic Clinics, 110 plus Telemedicine Centres and 80 plus Apollo Munich Insurance branches spanning the length and breadth of the Country.

As an integrated healthcare service provider with Health Insurance services, Global Projects Consultancy capability, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research Apollo Hospitals has been at the forefront of new medical breakthroughs with the most recent investment being that of commissioning the first Proton Therapy Center across Asia, Africa and Australia in Chennai, India.

Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of International standards within the reach of every individual.

In a rare honour, the Government of India issued a commemorative stamp in recognition of Apollo's contribution, the first for a healthcare organization.

Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010.

For more than 30 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology.

Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services and research. 

Last modified on Monday, 27 November 2017 03:49

Face Book Setup 02